Rahul Sarugaser analyst RAYMOND JAMES

Currently out of the existing stock ratings of Rahul Sarugaser, 19 are a BUY (79.17%), 5 are a HOLD (20.83%).

Rahul Sarugaser

Work Performance Price Targets & Ratings Chart

Analyst Rahul Sarugaser works at RAYMOND JAMES with a stock forecast success ratio of 38.19% fulfilled within 94.5 days on average.

Rahul Sarugaser’s has documented 44 price targets and ratings displayed on 11 stocks. The coverage is on Consumer Defensive, Technology, Healthcare sectors.

Most recent stock forecast was given on FUSN, Fusion Pharmaceuticals  at 05-Jan-2024.

Wall Street Analyst Rahul Sarugaser

Analyst best performing recommendations are on DNA (GINKGO BIOWORKS HOLDINGS).
The best stock recommendation documented was for DNA (GINKGO BIOWORKS HOLDINGS) at 10/13/2021. The price target of $14.5 was fulfilled within 6 days with a profit of $4.25 (41.46%) receiving and performance score of 69.11.

Average potential price target upside

SLHG Skylight Health Group VFF Village Farms International AI C3 Ai DNA Ginkgo Bioworks Holdings CRDL Cardiol Therapeutics PROF Profound Medical Corp CRON Cronos Group DBCCF Decibel Cannabis Company MEDXF Medexus Pharmaceuticals FUSN Fusion Pharmaceuticals  PNT POINT Biopharma Global

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$2.55 (566.67%)


1 years 10 months 21 days ago

0/2 (0%)

$1.87 (165.49%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Rahul Sarugaser is most bullish on?

Potential upside of $2.91 has been obtained for FUSN (FUSION PHARMACEUTICALS )

Which stock is Rahul Sarugaser is most reserved on?

Potential downside of -$0 has been obtained for PNT (POINT BIOPHARMA GLOBAL)

What Year was the first public recommendation made by Rahul Sarugaser?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?